Confusion, Rigidity, and Elevated Creatine Phosphokinase: Atypical Neuroleptic Malignant Syndrome Possibly Associated With Clozapine and Sodium Valproate Use

References (8)

1. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164(6):870–876. PubMed CrossRef
2. Cherry S, Siskind D, Spivak V, et al. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone? Australas Psychiatry. 2016;24(6):602–603. PubMed CrossRef
3. Uvais NA. Atypical neuroleptic malignant syndrome (NMS). Asian J Psychiatr. 2017;30:120–121. PubMed CrossRef
4. Belvederi Murri M, Guaglianone A, Bugliani M, et al. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D. 2015;15(1):45–62. PubMed CrossRef
5. Verma R, Junewar V, Rathaur BPS. An atypical case of neuroleptic malignant syndrome precipitated by valproate. BMJ Case Rep. 2014;2014:bcr2013202578. PubMed
6. Tanii H, Saka K, Inoue K, et al. Neuroleptic malignant syndrome following levomepromazine discontinuation. J Neuropsychiatry Clin Neurosci. 2010;22(2):E16. PubMed CrossRef
7. Yıldırım V, Direk MÇ, Güneş S, et al. Neuroleptic malignant syndrome associated with valproate in an adolescent. Clin Psychopharmacol Neurosci. 2017;15(1):76–78. PubMed CrossRef
8. Menon V, Rajkumar RP, Thamizh JS, et al. Atypical neuroleptic malignant syndrome in a young male precipitated by oral sodium valproate. Aust N Z J Psychiatry. 2016;50(12):1208–1209. PubMed CrossRef